Compare GSK plc (GSK) vs Direxion Daily Semiconductor Bull 3X Shares (SOXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? GSK plc trades at $46.52 (market cap $91.88B), while Direxion Daily Semiconductor Bull 3X Shares trades at $139.77 (market cap $24.42B). The key difference: GSK plc is far larger — about 3.8× Direxion Daily Semiconductor Bull 3X Shares's market cap, and GSK plc pays a 3.9% dividend while Direxion Daily Semiconductor Bull 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Direxion Daily Semiconductor Bull 3X Shares for 15 Days on average.
| GSK | SOXL | |
|---|---|---|
Market Cap | $91.88B | $24.42B |
Volume | 7,730,529 | 100,232,380 |
Sector | Health | Leveraged / Inverse |
52-Week High | $61.18 | $300.77 |
52-Week Low | $43.24 | $30.81 |
Typical Hold Time | 93 Days | 15 Days |
Enterprise Value | $111.88B | — |
Dividend Yield | 3.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.50, down 1.11% with bearish technical signals, though RSI levels suggest potential oversold conditions. Fundamentally, the company shows strong profitability with 72.73% gross margins and consistent earnings beats, while maintaining a reasonable P/E of 14.89. Recent developments include strategic oncology partnerships and a $750M cancer therapy acquisition, positioning for long-term growth despite facing an HIV patent cliff.
GSK presents a mixed investment case with strong fundamentals and pipeline growth offset by technical weakness and patent expiration risks. The company's £40B sales target and cost-saving initiatives provide upside potential, while analyst consensus leans cautious with 55% hold ratings. Key risks include execution of pipeline development and competitive pressures in core markets.
SOXL, the Direxion Daily Semiconductor Bull 3X ETF, is trading at $139.3, down 12.34% in the last 24 hours amid semiconductor sector volatility. Technical indicators show a bearish overall signal with mixed moving averages and neutral oscillators. The fund's leveraged structure amplifies both gains and losses in the semiconductor sector, which faces conflicting signals from strong AI demand versus concerns about valuation and regulatory risks.
The outlook for SOXL remains highly volatile, with opportunities tied to sustained AI-driven semiconductor demand but significant risks from the fund's 3x leverage structure and sector-specific headwinds. Investors face amplified exposure to semiconductor stock fluctuations, requiring careful risk management given the current bearish technical setup and mixed market sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Direxion Daily Semiconductor Bull 3X Shares
SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →
